Accendra Health stock analysis
Want to see ACCH full AI Analyst Report?
Accendra Health (ACCH) Stock Price & Analysis
ACCH Stock Chart & Stats
- Day’s Range
- $0.01 - $0.03
- 52-Week Range
- $0.01 - $4.69
- Previous Close
- $0.02
- Volume
- N/A
- Average Volume (3M)
- 4.76M
- Market Cap
- $1.49M
- Enterprise Value
- $1.87B
- Total Cash (Recent Filing)
- $26.61M
- Total Debt (Recent Filing)
- $1.85B
- Price to Earnings (P/E)
- ―
- Beta
- 1.36
- Next Earnings
- Feb 24, 2027 (Est.)
- EPS Estimate
- -0.24
- Last Dividend Ex-Date
- Dec 14, 2021
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Improved Cash Generation
The return to positive operating and free cash flow improves internal funding capacity and provides evidence that stabilization efforts are beginning to convert into cash. However, sustaining this improvement remains important because prior cash generation was volatile and recent operating cash flow is modest relative to business scale.
Liquidity And Debt Management
Substantial available liquidity and covenant compliance give the company room to execute its operational changes and manage near-term obligations. Debt reduction also supports financial flexibility, while the extended receivables facility provides an additional committed funding source through 2029.
Turnaround And Process Modernization
A defined transformation plan addresses several identified commercial and operational bottlenecks rather than relying on a single short-term action. If execution improves referrals, retention, collections, and process efficiency, it could strengthen recurring revenue quality and support more durable profitability.
Bears Say
Negative Stockholders’ Equity
Negative equity indicates a materially weakened capital structure and reduces financial flexibility even though total debt has declined. It can complicate refinancing and credit access, making execution more dependent on reliable cash generation and successful improvement in operating performance.
Revenue Decline And Ongoing Losses
The company has not yet restored durable earnings power: revenue has moved into decline and net profitability remains negative. The improvement from 2025 reduces the severity of losses but does not resolve the underlying challenge of returning to sustained growth and positive margins.
Operational Underperformance And Reduced Outlook
Share losses and weak patient retention, order execution, and collections can pressure both revenue and margins beyond a single quarter. The sharply reduced EBITDA outlook confirms that management expects these operational issues to weigh on near-term results while the turnaround remains unproven.
ACCH FAQ
What was Accendra Health’s price range in the past 12 months?
What is Accendra Health’s market cap?
When is Accendra Health’s upcoming earnings report date?
Is Accendra Health overvalued?
Does Accendra Health pay dividends?
What is Accendra Health’s EPS estimate?
How many shares outstanding does Accendra Health have?
Which hedge fund is a major shareholder of Accendra Health?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Accendra Health
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Kenneth Gardner-Smith
- Employees
- 6,500
- Website
- www.accendrahealth.com
- Address
- 4435 Waterfront Drive, Glen Allen, VA, 23060, US
ACCH Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 0 | 17 |
| Technical Analysis | 5 | 0 | 5 |
| Moving Averages | 0 | 0 | 12 |

